Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,414
The Small Intestine Bacterial Overgrowth Study Pilot
for
Systemic Sclerosis, Small Intestinal Bacterial Overgrowth
Location: Baltimore MD
Sponsor: Canadian Scleroderma Research Group
Sex: All
Age: 18+
Code: NCT03588845
Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Location: Baltimore MD, Philadelphia PA, New Brunswick NJ,
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT06080698
Recruiting
Circulating Tumor DNA
for
ER+ Breast Cancer
Location: Washington D.C. DC, Baltimore MD, The Bronx NY,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06923527
Phase2, Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
for
Prediabetic State, Atherosclerosis, Metformin
Location: Baltimore MD, Richmond VA, Salem VA, New York NY,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02915198
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: Baltimore MD, Charlottesville VA, New York NY,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase1, Phase2, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Washington D.C. DC, Arlington VA, Fairfax VA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase2, Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Location: Rockville MD, Norfolk VA, The Bronx NY, Bexley OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 17
Code: NCT05723198
Phase3, Recruiting
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Washington DC, Baltimore MD, Durham NC, Boston MA,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase1, Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Washington D.C. DC, McLean VA, Fairfax VA,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase3, Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: Washington D.C. DC, Fairfax VA, Alexandria VA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase2, Recruiting
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Fairfax VA, Baltimore MD, Montreal, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT04686305
Phase1, Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Rockville MD, Baltimore MD, Philadelphia PA,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase2, Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Washington D.C. DC, Silver Spring MD, Fairfax VA,